文献速递脊柱关节炎

希腊银屑病关节炎注册研究中潜在难治性银屑病关节炎患者的识别与特征:探索性分析

Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry.
PubMed 文献 · Rheumatology (Oxford) · 2024-01-01

基于希腊多中心银屑病关节炎注册研究467例患者,按至少6个月病程、失败于至少一种传统合成改善病情抗风湿药和至少两种不同作用机制的生物/靶向合成改善病情抗风湿药,且DAPSA>14和/或未达最小疾病活动度定义潜在难治性银屑病关节炎,检出77例(16.5%)。难治性患者更常见广泛银屑病、更高BMI和炎症性肠病史。

要点

  • 467例中77例(16.5%)符合潜在难治性银屑病关节炎定义。
  • 难治性患者广泛银屑病(P<0.0001)、更高BMI(P=0.023)和炎症性肠病史(P=0.026)更常见。
  • 仅按MODA或MDA标准的敏感性分析中,难治性比例分别为7.5%和12.5%,广泛银屑病均为独立相关变量。

核心结论

  • 尽管已有可用疗法,潜在难治性银屑病关节炎在真实世界银屑病关节炎队列中仍常见,且与广泛银屑病相关。
  • 高BMI、女性、中轴疾病和炎症性肠病史也与潜在难治性银屑病关节炎相关。

研究设计与样本

  • 希腊银屑病关节炎患者多中心注册研究的探索性分析,共纳入467例患者。
  • 潜在难治性银屑病关节炎定义为:病程至少6个月,且失败于至少一种传统合成改善病情抗风湿药和至少两种不同作用机制的生物/靶向合成改善病情抗风湿药,并满足DAPSA>14和/或未达最小疾病活动度。
  • 比较潜在难治性与非难治性银屑病关节炎患者的人口学和临床特征,并进行仅按MODA或仅按MDA标准分类的敏感性分析。

主要发现

  • 467例患者中77例(16.5%)为潜在难治性银屑病关节炎,390例为非难治性。
  • 与非难治性患者相比,潜在难治性患者更常见广泛银屑病(P<0.0001),更可能BMI更高(P=0.023)和有炎症性肠病史(P=0.026)。
  • 仅按MODA标准的敏感性分析中7.5%患者为潜在难治性,仅按MDA标准的敏感性分析中12.5%患者为潜在难治性。
  • 两项敏感性分析中,广泛银屑病均为潜在难治性银屑病关节炎的独立变量(P=0.001和P=0.008)。
  • MODA分析中女性(P=0.034)和MDA分析中中轴疾病(P=0.040)为潜在难治性银屑病关节炎的独立变量。

关键数值与推荐

  • 潜在难治性银屑病关节炎定义:病程至少6个月,失败于至少一种传统合成改善病情抗风湿药和至少两种不同作用机制的生物/靶向合成改善病情抗风湿药,且DAPSA>14和/或未达最小疾病活动度。
  • MODA定义为DAPSA>14。
  • MDA定义为最小疾病活动度(原文未给出具体标准)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To present the characteristics of patients with potential difficult-to-treat (D2T) PsA. METHODS: We used data from the Greek multicentre registry of PsA patients. D2T PsA was defined as follows: patients with at least 6 months' disease duration, who have failed to at least one conventional synthetic DMARD and at least two biologic DMARDs/targeted synthetic DMARDs with a different mechanism of action and have either at least moderate disease activity (MODA) defined as DAPSA (Disease Activity index in PSoriatic Arthritis) >14, and/or are not at minimal disease activity (MDA). Demographic and clinical characteristics were compared between D2T and non-D2T PsA patients. In two sensitivity analyses, patients classified as D2T solely according to the MODA or MDA criterion were examined separately. RESULTS: Among 467 patients included, 77 (16.5%) were considered D2T and 390 non-D2T PsA. Compared with non-D2T, patients with D2T PsA presented more commonly with extensive psoriasis (P < 0.0001) and were more likely to have higher BMI (P = 0.023) and a history of IBD (P = 0.026). In the MODA and MDA sensitivity analyses, 7.5% and 12.5% of patients were considered D2T, respectively. In both sensitivity analyses, extensive psoriasis was again identified as an independent variable for D2T PsA (P = 0.001 and P = 0.008, respectively). Moreover, female gender (P = 0.034) in the MODA analysis and axial disease (P = 0.040) in the MDA analysis were independent variables for D2T PsA. CONCLUSION: Despite the availability of therapies, D2T PsA is common in real-life cohorts of patients with PsA and extensive psoriasis. High BMI, female gender, axial disease and history of IBD were also associated with D2T PsA.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Vassilakis KD, Papagoras C, Fytanidis N, et al. Identification and characteristics of patients with potential difficult-to-treat psoriatic arthritis: exploratory analyses of the Greek PsA registry. Rheumatology (Oxford). 2024. PMID: 38759119. doi:10.1093/rheumatology/keae263

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。